tirzepatide for binge eating disorder GLP-1 receptor agonists: A novel pharmacotherapy (Binge eating and bulimia nervosa)? A systematic review Could weight-loss drugs treat more

Human epidemiological data from a 2023 pharmacovigilance study (N=1.3 million patient-years of GLP-1 exposure) did not show a significantly elevated MTC incidence, though the authors noted follow-up duration may be insufficient to detect a rare long-latency malignancy [9]

How long do IV fluids stay in the body

CHRIS RAYNER: Gary, there must be quite a subset of patients who are so comorbid with their extreme obesity, that they're not good surgical candidates

however, all subgroup findings should be regarded as exploratory

Diagnostic potential of eryptosis has been widely studied in diabetes mellitus (DM)

Improvements in insulin sensitivity, gut health and sleep tend to persist